Thermo Fisher Scientific has announced the launch of the first commercially available culture medium specifically developed for the expansion of patient-derived cancer organoids, from multiple cancer indications.

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, state-of-the-art facility.

Genomenon Inc. has announced it has acquired Boston Genetics, a genomics interpretation and curation company.

AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials.

Two towering JEOL Electron Microscopes stand ready to produce terabytes of valuable data for researchers at Generate:Biomedicines each day, who are accelerating drug discovery and development of novel therapeutics using machine learning and generative artificial intelligence.

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets.

The independent jury chaired by Prof. Reinhard Jahn selected Dr. Maurice Michel, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden as the winner of the Eppendorf Award for Young European Investigators 2023.

FUJIFILM Irvine Scientific, Inc. has announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization.

Owlstone Medical has announced new data on the development of novel tests for the detection of liver disease.

Sphere Fluidics announced Biosyntia, a biotechnology company focused on synthetic biology and metabolic engineering, has adopted the Pico-Mine® platform within its workflows.